SIC
ARKG icon

Sterling Investment Counsel’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sterling Investment Counsel’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,893
Closed -$271K – 148
2022
Q1 		$271K Buy
5,893
+801
+16% +$38.2K 0.18% 116
2021
Q4 		$312K Buy
+5,092
New +$352K 0.21% 104

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

Sterling Investment Counsel's ARKG Position: Q2 2022 in Review

Sterling Investment Counsel sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,893 shares — an estimated $271K sold.

Sterling Investment Counsel first reported a position in ARKG in Q4 2021 and held it in 2 quarters. The position peaked at $312K in Q4 2021. 334 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Sterling Investment Counsel reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Sterling Investment Counsel sold 5,893 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $271K.
  • Sterling Investment Counsel first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 2 quarters.
  • Sterling Investment Counsel's ARK Genomic Revolution ETF position peaked at $312K in Q4 2021.
  • 334 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Sterling Investment Counsel's 13F filing for Q2 2022, filed 18 Jul 2022.